Anton Simeonov

USPTO Granted Patents = 25 (Patent Applications = 10)

CIPO Patents = 8 (Patent Applications = 8)

EPO Patents = 12 (Patent Applications = 24)

Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 30(Granted Patents)

Location History:

Santa Cruz, CA (US) (2019)
Rockville, MD (US) (2017 - 2021)
Bethesda, MD (US) (2014 - 2024)

Company Filing History:

22 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

6 out of 1,153

Vanderbilt University

patents

6 out of 647

The UAB Research Foundation (The University of Alabama at Birmingham)

patents

4. 6 out of 2,597

University of Pennsylvania

patents

5. 4 out of 15,475

University of California

patents

6. 3 out of 1,929

University System of Maryland

patents

7. 3 out of 73

Children's National Medical Center

patents

8. 3 out of 50

Eastern Virginia Medical School

patents

9. 3 out of 528

Thomas Jefferson University

patents

10. 3 out of 517

Beth Israel Deaconess Medical Center, Inc.

patents

11. 2 out of 1,217

The United States of America As Represented by the Department of Health

patents

12. 2 out of 1,271

The University of North Carolina at Chapel Hill

University of Delaware

17. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12365653 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2025-07-22),

2. 11897845 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2024-02-13),

3. 11795177 - Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors (2023-10-24),

4. 11505559 - Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors (2022-11-22),

5. 11274077 - 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase (2022-03-15),

6. 11247971 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2022-02-15),

7. 11129835 - Methods and compositions for the inhibition of PIN1 (2021-09-28),

8. 11110089 - Pyridazinones and their use in the treatment of cancer (2021-09-07),

9. 10961200 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-30),

10. 10954228 - 1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-23),

11. 10899710 - Pyridines and their use in the treatment of cancer (2021-01-26),

12. 10881653 - Tricyclic compounds and their use in the treatment of cancer (2021-01-05),

13. 10836759 - Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer (2020-11-17),

14. 10752581 - 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase (2020-08-25),

15. 10703746 - Mutant IDH1 inhibitors useful for treating cancer (2020-07-07),

Title: Anton Simeonov: Pioneering Inventor from Bethesda

Introduction: Anton Simeonov is a renowned inventor based in Bethesda, MD, known for his groundbreaking contributions to the field of innovation and patents.

Latest Patents: Anton Simeonov holds several patents in various industries, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, Anton Simeonov has established himself as a leading figure in the world of inventions. His work has not only revolutionized existing technologies but has also paved the way for new advancements in the field.

Collaborations: Throughout his career, Anton Simeonov has collaborated with top research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines has led to the development of cutting-edge technologies with real-world applications.

Conclusion: In conclusion, Anton Simeonov's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.